Where does IVF stock trade?

INVO Fertility Inc. (IVF) is listed on NASDAQ.

What sector and industry is IVF in?

INVO Fertility Inc. operates in the Health Care sector, Medical/Dental Instruments industry.

What companies are similar to IVF?

Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare IVF side-by-side with any of them on Quantisnow.

How can I track IVF on Quantisnow?

Quantisnow aggregates INVO Fertility Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IVF to receive live email and push alerts on every new disclosure.

IVF

NASDAQ

INVO Fertility Inc.

SectorHealth CareIndustryMedical/Dental Instruments

News25/Ratings0

News · 26 weeks30+200%

2026-03-012026-08-23

Mix2190d

SEC Filings16(76%)
Other3(14%)
Dividends1(5%)
M&A1(5%)

Latest news

25 items

5dPR
INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International
SARASOTA, Fla., Aug. 20, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (NASDAQ:IVF) ("INVO Fertility" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced that Gretchen Collins, M.D., of the Company's Wisconsin-based clinic, Wisconsin Fertility Institute, presented five poster abstracts at the 2026 Midwest Reproductive Symposium international ("MRSi"), held on July 26-29, 2026, at The Drake Hotel in Chicago, Illinois. This year's meeting theme was "In Full Bloom – The Future of IVF." Dr. Collins is a double board-certified obstetrician-gynecologist and reprod
8dSEC
INVO Fertility Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - INVO Fertility, Inc. (0001417926) (Filer)
8dPR
INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability
Q2 2026 revenue increased 17% as INVO advances organic growth and a disciplined acquisition strategy focused on established, profitable fertility practices Clinic platform was profitable on an Adjusted EBITDA basis before corporate operating and public company expenses SARASOTA, Fla., Aug. 17, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (NASDAQ:IVF) ("INVO Fertility" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced financial results for the second quarter ended June 30, 2026. Q2 2026 Financial Highlights (all metrics compared to Q2 2025 unless otherwi
11dSEC
SEC Form 10-Q filed by INVO Fertility Inc.
10-Q - INVO Fertility, Inc. (0001417926) (Filer)
18dSEC
SEC Form 424B3 filed by INVO Fertility Inc.
424B3 - INVO Fertility, Inc. (0001417926) (Filer)
20dSEC
SEC Form EFFECT filed by INVO Fertility Inc.
EFFECT - INVO Fertility, Inc. (0001417926) (Filer)
32dSEC
SEC Form S-1 filed by INVO Fertility Inc.
S-1 - INVO Fertility, Inc. (0001417926) (Filer)
32dSEC
INVO Fertility Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
8-K - INVO Fertility, Inc. (0001417926) (Filer)
61dSEC
INVO Fertility Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events
8-K - INVO Fertility, Inc. (0001417926) (Filer)
63dSEC
SEC Form DEF 14A filed by INVO Fertility Inc.
DEF 14A - INVO Fertility, Inc. (0001417926) (Filer)
64dSEC
INVO Fertility Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - INVO Fertility, Inc. (0001417926) (Filer)
64dSEC
SEC Form 10-Q filed by INVO Fertility Inc.
10-Q - INVO Fertility, Inc. (0001417926) (Filer)
64dPR
INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure
23% revenue growth, elimination of all Series C-2 Preferred Stock and warrant liabilities, and a strengthened balance sheet Growth reflects both organic clinic initiatives and acquisition contribution from Family Beginnings, reinforcing INVO's two primary growth avenues SARASOTA, Fla., June 22, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (NASDAQ:IVF) ("INVO Fertility" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced financial results for the first quarter ended March 31, 2026. Q1 2026 Financial Highlights (all metrics compared to Q1
70dSEC
INVO Fertility Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - INVO Fertility, Inc. (0001417926) (Filer)
74dSEC
SEC Form PRE 14A filed by INVO Fertility Inc.
PRE 14A - INVO Fertility, Inc. (0001417926) (Filer)
74dSEC
Amendment: SEC Form 10-K/A filed by INVO Fertility Inc.
10-K/A - INVO Fertility, Inc. (0001417926) (Filer)
84dPR
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q
SARASOTA, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (NASDAQ:IVF) ("INVO" or the "Company"), a healthcare services fertility company, today announced that on May 27, 2026, it received a delinquency notice (the "Notice") from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC"). The Notice relates to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the "10-K"), and its Quarterly Report on Form
84dSEC
INVO Fertility Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - INVO Fertility, Inc. (0001417926) (Filer)
84dSEC
SEC Form 10-K filed by INVO Fertility Inc.
10-K - INVO Fertility, Inc. (0001417926) (Filer)
84dSEC
INVO Fertility Inc. filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial Statements and Exhibits
8-K - INVO Fertility, Inc. (0001417926) (Filer)
84dPR
INVO Fertility Announces Fiscal Year 2025 Financial Results
SARASOTA, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (NASDAQ:IVF) ("INVO Fertility" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced fiscal year 2025 financial results. FY2025 Financial Highlights (all metrics compared to FY2024 unless otherwise noted) Revenue was $6,841,250, an increase of 5% compared to $6,532,000.Consolidated clinic revenue increased 4% to $6,721,057, compared to $6,450,431.Revenue from all clinics was $8,021,929, including both consolidated and equity method clinics, an increase of 4% compared to $7,731,177.Net loss
99dSEC
SEC Form NT 10-Q filed by INVO Fertility Inc.
NT 10-Q - INVO Fertility, Inc. (0001417926) (Filer)
118dSEC
INVO Fertility Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - INVO Fertility, Inc. (0001417926) (Filer)
118dPR
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K
SARASOTA, Fla., April 29, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (NASDAQ:IVF) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced reproductive treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced that on April 23, 2026, it received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule"), which requires listed companies to timely file all required periodic financial reports with the Se
146dSEC
SEC Form SCHEDULE 13G filed by INVO Fertility Inc.
SCHEDULE 13G - INVO Fertility, Inc. (0001417926) (Subject)

IVF FAQ

4 questions

Where does IVF stock trade?
INVO Fertility Inc. (IVF) is listed on NASDAQ.
What sector and industry is IVF in?
INVO Fertility Inc. operates in the Health Care sector, Medical/Dental Instruments industry.
What companies are similar to IVF?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare IVF side-by-side with any of them on Quantisnow.
How can I track IVF on Quantisnow?
Quantisnow aggregates INVO Fertility Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IVF to receive live email and push alerts on every new disclosure.